| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $13,999,128 ) |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01CA240747 | Feasibility and Assessment of a Cascade Traceback Screening program - FACTS | 001 | 4 | NIH | 5/26/2023 | $658,560 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | T6249313 | Integrated Substance Use Disorder (SUD) Training Program | 01 | 1 | HRSA | 7/25/2023 | $8,572 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | T6249313 | Integrated Substance Use Disorder (SUD) Training Program | 00 | 1 | HRSA | 6/9/2023 | $514,826 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R61DA059880 | Evaluation of a peer recovery support program adapted to target retention in clinic-based medication for opioid use disorder treatment | 000 | 1 | NIH | 9/21/2023 | $943,458 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01MH119705 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | 000 | 5 | NIH | 3/20/2023 | $173,767 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 00 | 1 | CDC | 8/23/2023 | $650,000 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01MH119705 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | 000 | 5 | NIH | 3/20/2023 | $315,563 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | P1349602 | Rural Residency Planning and Development Program | 01 | 1 | HRSA | 9/7/2023 | $0 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | P1349602 | Rural Residency Planning and Development Program | 00 | 1 | HRSA | 7/11/2023 | $749,594 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 000 | 2 | NIH | 2/2/2023 | $731,243 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL159182 | Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH) | 000 | 2 | NIH | 6/20/2023 | $738,253 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL141901 | A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy | 002 | 5 | NIH | 3/6/2023 | $62,602 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HD104938 | Characterizing the spectrum of genomic and phenotypic variation in cerebral palsy | 000 | 2 | NIH | 7/30/2023 | $680,237 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL141901 | A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy | 001 | 5 | NIH | 12/27/2022 | $563,407 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 000 | 2 | SAMHSA | 6/28/2023 | $523,545 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | UG1CA189847 | Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) | 000 | 10 | NIH | 8/1/2023 | $1,554,577 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 00 | 2 | HRSA | 3/15/2023 | $349,993 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HG011799 | Real-time genetic diagnosis at the point of care | 000 | 3 | NIH | 6/15/2023 | $921,082 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH074090 | Gene Dosage Imbalance in Neurodevelopmental Disorders | 000 | 17 | NIH | 1/20/2023 | $791,368 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | H2A39958 | Telehealth Network Grant Program | 00 | 4 | HRSA | 7/20/2023 | $297,655 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | U18DP006509 | Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania | 00 | 4 | CDC | 5/29/2023 | $54,005 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | U18DP006509 | Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania | 00 | 4 | CDC | 5/29/2023 | $195,995 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | K01DA049903 | Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy | 000 | 4 | NIH | 6/12/2023 | $162,032 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | D5837570 | Residency Training in Primary Care | 00 | 4 | HRSA | 4/28/2023 | $498,142 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | D5837570 | Residency Training in Primary Care | 01 | 4 | HRSA | 5/23/2023 | $47,619 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | T2537597 | Addiction Medicine Fellowship | 01 | 4 | HRSA | 9/15/2023 | $37,104 |
| | 2023 | 2023 | Geisinger Clinic | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | T2537597 | Addiction Medicine Fellowship | 00 | 4 | HRSA | 5/2/2023 | $539,499 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01MH119705 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | 000 | 5 | NIH | 3/20/2023 | $1,337,391 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HL146188 | Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | 001 | 4 | NIH | 4/10/2023 | $639,186 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL141901 | A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy | 000 | 4 | NIH | 11/30/2022 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 002 | 1 | SAMHSA | 9/21/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HG009671 | Reporting Adult-Onset Genomic Results to Pediatric Biobank Participants and Parents | 000 | 5 | NIH | 2/16/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 001 | 1 | SAMHSA | 7/19/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | NU58DP006962 | Supplemental Funding to Support COVID-19 and Influenza Vaccine in Cambiamos and Scranton | 01 | 2 | CDC | 5/8/2023 | -$276,895 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H2A39958 | Telehealth Network Grant Program | 04 | 3 | HRSA | 6/5/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H2A39958 | Telehealth Network Grant Program | 03 | 3 | HRSA | 4/12/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H2A39958 | Telehealth Network Grant Program | 02 | 3 | HRSA | 3/15/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | U18DP006509 | Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania | 00 | 4 | CDC | 5/29/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | U18DP006509 | Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania | 00 | 4 | CDC | 5/29/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | D5837570 | Residency Training in Primary Care | 01 | 3 | HRSA | 5/1/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01CA240747 | Feasibility and Assessment of a Cascade Traceback Screening program - FACTS | 000 | 3 | NIH | 4/6/2023 | $0 |
| | 2023 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HL146188 | Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | 000 | 3 | NIH | 12/13/2022 | $0 |
| | 2023 | 2021 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | U01DP006296 | Component A: A multi-level study of community context and type 2 diabetes and coronary heart disease using electronic health record and new primary data across nested geographies in Pennsylvania | 01 | 5 | CDC | 10/14/2022 | $0 |
| | 2023 | 2021 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | NU58DP006962 | Supplemental Funding to Support COVID-19 and Influenza Vaccine in Cambiamos and Scranton | 01 | 2 | CDC | 5/8/2023 | -$437,250 |
| | 2023 | 2021 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | 90C30023 | KeyHIE_STAR | 06 | 1 | DHHS/OS | 11/23/2022 | $0 |
| | 2023 | 2020 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | U01DP006296 | Component A: A multi-level study of community context and type 2 diabetes and coronary heart disease using electronic health record and new primary data across nested geographies in Pennsylvania | 01 | 5 | CDC | 10/14/2022 | $0 |
| | 2023 | 2019 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | U01DP006296 | Component A: A multi-level study of community context and type 2 diabetes and coronary heart disease using electronic health record and new primary data across nested geographies in Pennsylvania | 01 | 5 | CDC | 10/14/2022 | $0 |
| | 2023 | 2019 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH107431 | Dimensional analysis of developmental brain disorders using an online, genome-first approach | 000 | 5 | NIH | 7/14/2023 | -$26,002 |
|
| Issue Date FY: 2022 ( Subtotal = $13,665,868 ) (Continued on the next page) |
|
